Connection
Tomoo Iwakuma to High-Throughput Screening Assays
This is a "connection" page, showing publications Tomoo Iwakuma has written about High-Throughput Screening Assays.
|
|
Connection Strength |
|
 |
|
 |
|
0.076 |
|
|
|
-
Parrales A, McDonald P, Ottomeyer M, Roy A, Shoenen FJ, Broward M, Bruns T, Thamm DH, Weir SJ, Neville KA, Iwakuma T, Fulbright JM. Comparative oncology approach to drug repurposing in osteosarcoma. PLoS One. 2018; 13(3):e0194224.
Score: 0.039
-
Sasaki K, Kurahara H, Young ED, Natsugoe S, Ijichi A, Iwakuma T, Welch DR. Genome-wide in vivo RNAi screen identifies ITIH5 as a metastasis suppressor in pancreatic cancer. Clin Exp Metastasis. 2017 04; 34(3-4):229-239.
Score: 0.036